Jefferies Financial Group Inc. Purchases 21,853 Shares of Corteva, Inc. $CTVA

Jefferies Financial Group Inc. increased its position in shares of Corteva, Inc. (NYSE:CTVA) by 105.2% in the 4th quarter, HoldingsChannel reports. The firm owned 42,632 shares of the company’s stock after acquiring an additional 21,853 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Corteva were worth $2,858,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Activest Wealth Management lifted its position in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter worth about $25,000. Redmont Wealth Advisors LLC bought a new stake in Corteva during the third quarter worth about $29,000. Jackson Grant Investment Advisers Inc. lifted its position in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the period. Finally, Measured Wealth Private Client Group LLC bought a new stake in Corteva during the third quarter worth about $33,000. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Down 0.5%

CTVA opened at $79.20 on Wednesday. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a fifty day moving average of $81.32 and a 200-day moving average of $74.27. The stock has a market cap of $52.97 billion, a PE ratio of 46.59, a price-to-earnings-growth ratio of 2.43 and a beta of 0.59.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the subject of several recent analyst reports. Berenberg Bank upped their price objective on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. The Goldman Sachs Group upped their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. UBS Group increased their target price on shares of Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. BNP Paribas Exane increased their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and increased their target price for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.